This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of John Malmberg
Introduction: John Malmberg, an accomplished inventor based in Södertälje, Sweden, has made significant strides in the field of pharmaceutical compounds. With one notable patent to his name, his work reflects a dedication to developing new therapeutic solutions that could enhance patient care and treatment options.
Latest Patents: Malmberg holds a patent related to novel compounds expressed in the formula I. The patent details not only the new compounds but also the processes for their preparation, the intermediates involved, and the pharmaceutical formulations that incorporate these compounds. This innovation positions Malmberg at the forefront of new therapeutic advancements.
Career Highlights: Throughout his career, Malmberg has been associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on pharmaceutical research and development, contributing to the discovery of new compounds aimed at improving health outcomes.
Collaborations: At AstraZeneca, Malmberg has collaborated with notable colleagues such as Jalaj Arora and Louise G. Edwards. These collaborative efforts have fostered an environment of innovation and teamwork, driving the advancement of pharmaceutical research.
Conclusion: John Malmberg’s contributions to the field of pharmaceuticals, particularly with his patent on novel compounds, demonstrate his role as an influential inventor in the industry. His work at AstraZeneca AB and collaborations with esteemed coworkers highlight the importance of teamwork in pushing the boundaries of medical science. As he continues to innovate, the impact of his inventions is sure to resonate within the pharmaceutical community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
